Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
7.87
-0.12 (-1.50%)
At close: May 22, 2026, 4:00 PM EDT
7.94
+0.07 (0.89%)
After-hours: May 22, 2026, 7:32 PM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $382.39 million as of May 22, 2026. Its market cap has increased by 619.97% in one year.
Market Cap
382.39M
Enterprise Value
305.87M
1-Year Change
619.97%
Ranking
Category
Stock Price
$7.87
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $382.39M, an increase of 116.34%. That is a compound annual growth rate of 52.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 382.39M | 263.15% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 405.43M |
| Lexeo Therapeutics | 401.25M |
| C4 Therapeutics | 392.24M |
| Benitec Biopharma | 385.80M |
| InflaRx | 384.43M |
| OmniAb | 384.18M |
| Greenwich LifeSciences | 383.08M |
| X4 Pharmaceuticals | 381.05M |